Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Laurus Labs Ltd.
NSE: LAURUSLABS
|
BSE: 540222
|
ISIN: INE947Q01028
|
Industry: Pharmaceuticals
|
Mid-range Performer
967.7000
6.90
(
0.72
%)
NSE
Mar 17, 2026
12:34 PM
86.94% Gain from 52W Low
Volume:
916.7K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Laurus Labs Ltd.
29 Apr 2024
967.70
0.72%
Laurus Labs Limited
Neutral:
Laurus Labs Ltd.
by
Keynote Capitals Ltd
Target: 445
Recommendation
Target
Keynote Capitals Ltd
Quarterly Update Q4FY24
Laurus Labs has gained
68.57%
in the last 1 Year
More from Laurus Labs Ltd.
Recommended
Market trades flat, NOCIL's board approves a capex of Rs 130 crore
Trendlyne Marketwatch |
17 Mar 2026, 12:13PM
IPO market remains active despite weak retail demand and a volatile market
|
16 Mar 2026, 05:41PM
Earnings Call Transcript - Q1FY21 for Laurus Labs
|
31 Jul 2020